Intercultural Usage of Mori Folium: Comparison Review from a Korean Medical Perspective
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Joh, Byungjin | - |
dc.contributor.author | Jeon, Fun Sang | - |
dc.contributor.author | Lim, Su Hye | - |
dc.contributor.author | Park, Yu Lee | - |
dc.contributor.author | Park, Wansu | - |
dc.contributor.author | Chae, Han | - |
dc.date.available | 2020-02-28T15:41:42Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 1741-427X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/11954 | - |
dc.description.abstract | Objectives. A review on studies related to the use of Mori folium, the leaves of N o s aiba, was conducted with the goal of identifying new clinical applications in Korean medicine. Methods. Global literature search was conducted using three electronic databases up to January 2015 with the term Moms alba and its Korean terms. KM literatures including textbooks and standard pharmacopoeia were separately hand-searched and reviewed to provide comparison. Data were extracted according to predetermined criteria, and clinical uses were standardized with ICD-10 categories. Results. 159 potentially relevant studies were identified, and 18 articles including 12 ethnopharmacologic and 6 clinical studies were finally included in this analysis. Ethnopharmacologic studies from 8 countries provided 17 clinical uses. We found that five out of six clinical trials were related to diabetes and suggested a moderate short-term to mild long-term effect. And 43 Korean texts also provided 156 clinical uses in 35 categories including ocular and respiratory disorders. Discussion and Conclusions. Though majority of the clinical uses were also found in Korean medicine literature, treatment of infertility, jaundice, cognitive disorder, and hyperpigmentation was found to be effective and diabetes with Monts alba was recognized to have clinical importance. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | HINDAWI LTD | - |
dc.relation.isPartOf | EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE | - |
dc.subject | MEDICINAL-PLANTS | - |
dc.subject | ETHNOBOTANICAL SURVEY | - |
dc.subject | DISTRICT | - |
dc.subject | TURKEY | - |
dc.subject | INDIA | - |
dc.subject | INHIBITION | - |
dc.subject | TAMILNADU | - |
dc.subject | PAKISTAN | - |
dc.subject | EUGENOL | - |
dc.subject | TRIALS | - |
dc.title | Intercultural Usage of Mori Folium: Comparison Review from a Korean Medical Perspective | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000363587400001 | - |
dc.identifier.doi | 10.1155/2015/379268 | - |
dc.identifier.bibliographicCitation | EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE | - |
dc.identifier.scopusid | 2-s2.0-84946068536 | - |
dc.citation.title | EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE | - |
dc.contributor.affiliatedAuthor | Park, Wansu | - |
dc.type.docType | Review | - |
dc.subject.keywordPlus | MEDICINAL-PLANTS | - |
dc.subject.keywordPlus | ETHNOBOTANICAL SURVEY | - |
dc.subject.keywordPlus | DISTRICT | - |
dc.subject.keywordPlus | TURKEY | - |
dc.subject.keywordPlus | INDIA | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | TAMILNADU | - |
dc.subject.keywordPlus | PAKISTAN | - |
dc.subject.keywordPlus | EUGENOL | - |
dc.subject.keywordPlus | TRIALS | - |
dc.relation.journalResearchArea | Integrative & Complementary Medicine | - |
dc.relation.journalWebOfScienceCategory | Integrative & Complementary Medicine | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.